SYK STRYKER CORP
2026Q1 · CUSIP 863667101 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
2,288
Δ holders QoQ
-34
Breadth percentile
Top 96%
Whale holders
344
Δ whales
+1
Inst. holding value
$93.2B
New positions
163
Closed positions
197
Price momentum (1Q)
-14.9%
Put / Call
27/26
Breadth history (34 quarters)
Past Lit Events & Aftermath 23 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 9% | -14.9% | — |
| 2025Q2 | Top 8% | -4.9% | -0.7% |
| 2025Q1 | Top 7% | -1.0% | -8.4% |
| 2024Q4 | Top 2% | +2.6% | +1.6% |
| 2024Q3 | Top 5% | -1.5% | -2.4% |
| 2024Q1 | Top 1% | +2.1% | +17.1% |
| 2023Q4 | Top 3% | -4.0% | -1.9% |
| 2023Q2 | Top 1% | +0.8% | +24.5% |
Options Sentiment
Put holders
27
QoQ: -3
Call holders
26
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
35.9
EPS (TTM)
$8.64
EPS YoY
+16.8%
Revenue (TTM)
$25.3B
Revenue YoY
+8.8%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)